CD36 and dry age related macular degeneration: Combined with their known anti-inflammatory effect, the ability of azapeptide CD36 ligands to modulate oxidative stress offers potential for preserving RPE and photoreceptor integrity and a novel strategy for remedying the pathogenesis of dry AMD.